Analysts Predict Growth for Tech and Pharma Stocks Despite Economic Uncertainty

CNBC Pro hosting a talk on financial planning, with analysts suggesting potential catalysts for an AI stock.
Pharma stock expected to bounce back and provide long-term earnings growth according to analysts.
Software development firm predicted to grow sales by eight times current levels per analysts.
Blood cancer treatment stock could gain 70% ahead of planned drug launch per Goldman Sachs.
Home appliance stock forecasted to increase over 90% due to brand growth by Jefferies.